MMR mass vaccination campaigns, vaccine-related adverse events, and the limits of the decision making process, in Brazil

Health Policy

Volumn 67, Issue 3, 2004, Pages 323-328

  Cunha, Sérgio C ^a   Dourado, Inês ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Mass immunisation campaigns; MMR; Pre licensure studies

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

BRAZIL; DECISION MAKING; HEALTH CARE FACILITY; HEALTH CARE PLANNING; HEALTH PROMOTION; HUMAN; INTERPERSONAL COMMUNICATION; MASS IMMUNIZATION; MENINGITIS; REVIEW; RISK; VACCINATION REACTION;

EID: 1242269976     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2003.07.008     Document Type: Article

References (17)

1. Chen R.T., Orenstein W.A. Epidemiologic methods in immunization programs. Epidemiologic Reviews. 18:1996;99-117.
2. Galazka A.M., Robertson S.E., Kraigher A. Mumps and mumps vaccine: a global review. Bulletin of the World Health Organization. 77:1999;3-14.
3. Tuboi SH, Simoneti JLS, Capobianco JD, et al. Prevalência de meningite asséptica pós vacina tríplice viral (prevalence of aseptic meningitis after measles-mumps-rubella vaccine). Universidade Estadual de Londrina-Paraná: Londrina-State of Paraná-Brazil, 1995.
4. Moreira CMA, Cortez MR, Morais SZ, et al. Análise das reações adversas à vacina triplíce viral notificadas à diretoria metropolitana de saúde de Belo Horizonte, MG, 1997 [Assessment of adverse events due to MMR vaccine, notified to the metropolitan health directory of Belo Horizonte, State of Minas Gerais]. In: IV Congresso Brasileiro de Epidemiologia, Rio de Janeiro, 1998.
5. Boaventura S, Famer S, Ranieri TMS, et al. Avaliação de reatogenicidade de três vacinas tríplice viral (sarampo, caxumba, e rubéola). [Avaliation of reactogenicity of three measles-mumps-rubella vaccines]. In: IV Congresso Brasileiro de Epidemiologia, EPIRIO, Rio de Janeiro, Brazil, 1998.
6. dos Santos B.A., Ranieri T.S., Bercini M.et al. An evaluation of the adverse reaction potential of three measles-mumps-rubella combination vaccines. Revista Panamericana de Salud Publica. 12:2002;240-245.
7. Miller E., Goldacre M., Pugh S.et al. Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children [see comments]. Lancet. 341(8851):1993;979-982.
8. Cunha S.S., Dourado I., Barreto M.L.et al. Associação entre meningite asséptica e uso da vacina tríplice viral (sarampo, caxumba, rubéola) durante a campanha vacinal de 1997. IESUS. 7:1998;29-61.
9. Dourado I., Cunha S.C., Teixeira M.G.et al. An outbreak of aseptic meningitis associated with MMR mass vaccination campaign: implications for immunization programs. American Journal of Epidemiology. 151:2000;1-7.
10. Silveira C.M., Kmetzsch C.I., Mohrtdieck R.et al. The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997. International Journal of Epidemiology. 31:2002;978-982.
11. Beck M., Smerdel S., Dedic I.et al. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine. Development Biology Standards. 65:1986;95-100.
12. Tesovic G., Begovac J., Bace A. Aseptic meningitis after measles, mumps, and rubella vaccine [letter comment]. Lancet. 341(8859):1993;1541.
13. Cunha S.S., Rodrigues L.C., Barreto L.M.et al. Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain. Vaccine. 20:2002;1106-1112.
14. Arruda W.O., Kondageski C. Aseptic meningitis in a large MMR vaccine campaign (590,609 people) in Curitiba, Paraná, Brazil, 1998. Revista do Instituto de Medicina Tropical de Sao Paulo. 43:2001;301-302.
15. Upshur R.E.G. Principles for the justification of public health intervention. Canadian Journal of Public Health. 93:2002;101-103.
16. Rothman KJ. Modern epidemiology. 1st ed. Boston, USA: Little, Brown and Company; 1986.
17. PAHO. Evaluation of the Bahamas' MMR campaign. Epi News Lett. 1999;21:4-5.